Clinical Trials: Study Design, Endpoints and Biomarkers, Drug Safety, and FDA and ICH Guidelines is a practical guidebook for those engaged in clinical trial design. This book details the organizations and content of clinical trials, including trial design, safety, endpoints, subgroups, HRQoL, consent forms and package inserts. It provides extensive information on both US and international regulatory guidelines and features concrete examples of study design from the medical literature. This book is intended to orient those new to clinical trial design and provide them with a better understanding of how to conduct clinical trials. It will also act as a guide for the more experienced by detailing endpoint selection and illustrating how to avoid unnecessary pitfalls. This book is a straightforward and valuable reference for all those involved in clinical trial design. It provides extensive coverage of the "study schema" and related features of study design. It offers a "hands-on" reference that contains an overview of the process, but more importantly details a step-by-step account of clinical trial design. It features examples from the medical literature to highlight how investigators choose the most suitable endpoint(s) for clinical trial and includes graphs from real clinical trials to help explain each concept in study design. It integrates clinical trial design, pharmacology, biochemistry, cell biology and legal aspects to provide readers with a comprehensive look at all aspects of clinical trials. It includes chapters on core material and important ancillary topics, such as package inserts, consent forms, and safety reporting forms used in the United States, England and Europe.
"synopsis" may belong to another edition of this title.
".A solid guide to designing clinical trials for medical scientists, especially those working in oncology, immune disease, and infectious disease.Three chapters address quality-of-life topics." -Selected for The First Clinical Research Bookshelf, "Essential Reading for Clinical Research Professionals," Journal of Clinical Research Best Practices, September 2012, Vol. 8, No. 9About the Author:
Dr. Tom Brody received his Ph.D. from the University of California at Berkeley in 1980 and has published several research articles in the areas of enzymology, metabolism and pharmacokinetics of folates and related amino acids. For his post-doctoral work, also at U.C. Berkeley, the author cloned, sequenced, and expressed an oncogene, and purified the encoded protein (xeroderma pigmentosum E; XPE). The XPE gene encodes a DNA repair protein. Later, he performed research on the structure of an antibody (natalizumab) used for treating multiple sclerosis. At an earlier time, he wrote two editions of Nutritional Biochemistry, published by Elsevier, Inc. The author is a registered patent agent.
"About this title" may belong to another edition of this title.
Book Description Academic Pr, 2011. Hardcover. Book Condition: Brand New. 1st edition. 672 pages. 9.50x7.75x1.50 inches. In Stock. Bookseller Inventory # zk0123919118
Book Description Academic Press, 2011. Hardcover. Book Condition: New. 1. Bookseller Inventory # DADAX0123919118
Book Description Academic Press 2011-11-25, 2011. Hardcover. Book Condition: New. 1. 0123919118. Bookseller Inventory # 673813
Book Description Academic Press, 2011. Hardcover. Book Condition: New. book. Bookseller Inventory # 0123919118
Book Description Academic Press, 2011. Hardcover. Book Condition: New. Bookseller Inventory # P110123919118